Stitcher for Podcasts

Get the App Open App
Bummer! You're not a
Stitcher Premium subscriber yet.
Learn More
Start Free Trial
$4.99/Month after free trial

Show Info

Episode Info

Episode Info:

In July 2018, the Centers for Medicare and Medicaid Services (CMS) proposed new rules regarding the implementation of the Medicare Part B Improvement Act and section 5012 of the 21st Century Cures Act which directly affect the home infusion industry. The new rules and requirements have raised serious concerns among industry stakeholders, that if not addressed, stand to adversely compromise the marketplace as a whole. In this special episode, Kendall Van Pool, vice president of government affairs at the National Home Infusion Association (NHIA), joins host CSI Specialty Group President and CEO Suzette DiMascio, CHE, CMCE, CPC, to discuss the latest developments and challenges in the home infusion marketplace. He also shares how listeners can make a positive impact on the future of home infusion with a key hearing taking place this week.


Discover more stories like this.

Like Stitcher On Facebook


Episode Options

Listen Whenever

Similar Episodes

Related Episodes